Skip to main content

Forefront Analytics, LLC

SEC CIK
0001696802
Latest filing
Aug 12, 2026

Holdings changes from Q3 2024 to Q4 2024

Long positions only; new, added, reduced and sold out are based on share counts. Pick any two quarters this institution filed.

Choose two quarters to compare

New
4
Est. +$19.4M
Added
35
Est. +$41.6M
Reduced
25
Est. −$36.8M
Sold out
7
Est. −$12.7M

Portfolio value went from $212.0M to $215.0M (+$2.98M (+1.4%)); positions from 67 to 64 (−3).

All Q4 2024 holdingsAll Q3 2024 holdings

In the shares, value and % of portfolio columns, the top figure is Q4 2024 and the gray one below is Q3 2024. For stocks that split between the two quarters, Q3 2024 shares are converted at the split ratio before comparing.

Holdings of Forefront Analytics, LLC in Q3 2024 and Q4 2024 compared
SecurityActionSharesShare changeValueEst. bought or sold% of portfolioWeight change (pp)
Flexshares Tr33939L688Sold out–053,144−53,144−100.0%$0$9.17M−$9.17M0.0%4.3%−4.32
Invesco Exchange Traded FD T46137V837Sold out–016,690−16,690−100.0%$0$1.72M−$1.72M0.0%0.8%−0.81
iShares Tr464287432Sold out–05,035−5,035−100.0%$0$493.9K−$493.9K0.0%0.2%−0.23
Schwab U.S. Small-Cap ETF808524607Sold outConverted for a 2-for-1 split–018,024−18,024−100.0%$0$464.1K−$464.1K0.0%0.2%−0.22
Vanguard Emerging Markets Government Bond ETF921946885Sold out–05,776−5,776−100.0%$0$383.3K−$383.3K0.0%0.2%−0.18
iShares Tr46434V647Sold out–013,261−13,261−100.0%$0$353.9K−$353.9K0.0%0.2%−0.17
PSTXPoseida Therapeutics, Inc.Sold outHistory027,855−27,855−100.0%$0$79.7K−$79.7K0.0%<0.1%−0.04

Estimated amounts multiply the change in shares by the quarter-end price implied by the filing (market value divided by shares): new positions use this quarter's value and sold-out positions last quarter's; positions reported only as principal (PRN) cannot be estimated. 13F shows only quarter-end holdings, not when trades happened or at what price.